241 related articles for article (PubMed ID: 30842218)
21. Global regulation of alternative RNA splicing by the SR-rich protein RBM39.
Mai S; Qu X; Li P; Ma Q; Cao C; Liu X
Biochim Biophys Acta; 2016 Aug; 1859(8):1014-24. PubMed ID: 27354116
[TBL] [Abstract][Full Text] [Related]
22. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms.
Przychodzen B; Jerez A; Guinta K; Sekeres MA; Padgett R; Maciejewski JP; Makishima H
Blood; 2013 Aug; 122(6):999-1006. PubMed ID: 23775717
[TBL] [Abstract][Full Text] [Related]
23. U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review).
Nian Q; Li Y; Li J; Zhao L; Rodrigues Lima F; Zeng J; Liu R; Ye Z
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975232
[TBL] [Abstract][Full Text] [Related]
24. U2AF1 mutations alter splice site recognition in hematological malignancies.
Ilagan JO; Ramakrishnan A; Hayes B; Murphy ME; Zebari AS; Bradley P; Bradley RK
Genome Res; 2015 Jan; 25(1):14-26. PubMed ID: 25267526
[TBL] [Abstract][Full Text] [Related]
25. Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis.
Gurule NJ; Malcolm KC; Harris C; Knapp JR; O'Connor BP; McClendon J; Janssen WJ; Lee FFY; Price C; Osaghae-Nosa J; Wheeler EA; McMahon CM; Pietras EM; Pollyea DA; Alper S
Leukemia; 2023 Oct; 37(10):2115-2124. PubMed ID: 37591942
[TBL] [Abstract][Full Text] [Related]
26. U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation.
Park SM; Ou J; Chamberlain L; Simone TM; Yang H; Virbasius CM; Ali AM; Zhu LJ; Mukherjee S; Raza A; Green MR
Mol Cell; 2016 May; 62(4):479-90. PubMed ID: 27184077
[TBL] [Abstract][Full Text] [Related]
27. Promoter R-Loops Recruit U2AF1 to Modulate Its Phase Separation and RNA Splicing.
He X; Yuan J; Gao Z; Wang Y
J Am Chem Soc; 2023 Oct; 145(39):21646-21660. PubMed ID: 37733759
[TBL] [Abstract][Full Text] [Related]
28. A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex.
Chatrikhi R; Feeney CF; Pulvino MJ; Alachouzos G; MacRae AJ; Falls Z; Rai S; Brennessel WW; Jenkins JL; Walter MJ; Graubert TA; Samudrala R; Jurica MS; Frontier AJ; Kielkopf CL
Cell Chem Biol; 2021 Aug; 28(8):1145-1157.e6. PubMed ID: 33689684
[TBL] [Abstract][Full Text] [Related]
29. mTOR-regulated U2af1 tandem exon splicing specifies transcriptome features for translational control.
Chang JW; Yeh HS; Park M; Erber L; Sun J; Cheng S; Bui AM; Fahmi NA; Nasti R; Kuang R; Chen Y; Zhang W; Yong J
Nucleic Acids Res; 2019 Nov; 47(19):10373-10387. PubMed ID: 31504847
[TBL] [Abstract][Full Text] [Related]
30. U2af1 is a haplo-essential gene required for hematopoietic cancer cell survival in mice.
Wadugu BA; Nonavinkere Srivatsan S; Heard A; Alberti MO; Ndonwi M; Liu J; Grieb S; Bradley J; Shao J; Ahmed T; Shirai CL; Khanna A; Fei DL; Miller CA; Graubert TA; Walter MJ
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34546980
[TBL] [Abstract][Full Text] [Related]
31. The core spliceosomal factor U2AF1 controls cell-fate determination via the modulation of transcriptional networks.
Laaref AM; Manchon L; Bareche Y; Lapasset L; Tazi J
RNA Biol; 2020 Jun; 17(6):857-871. PubMed ID: 32150510
[TBL] [Abstract][Full Text] [Related]
32. Cancer-Associated Mutations Mapped on High-Resolution Structures of the U2AF2 RNA Recognition Motifs.
Glasser E; Agrawal AA; Jenkins JL; Kielkopf CL
Biochemistry; 2017 Sep; 56(36):4757-4761. PubMed ID: 28850223
[TBL] [Abstract][Full Text] [Related]
33. The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies.
Zhao Y; Cai W; Hua Y; Yang X; Zhou J
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139566
[TBL] [Abstract][Full Text] [Related]
34. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia.
Shiozawa Y; Malcovati L; Gallì A; Sato-Otsubo A; Kataoka K; Sato Y; Watatani Y; Suzuki H; Yoshizato T; Yoshida K; Sanada M; Makishima H; Shiraishi Y; Chiba K; Hellström-Lindberg E; Miyano S; Ogawa S; Cazzola M
Nat Commun; 2018 Sep; 9(1):3649. PubMed ID: 30194306
[TBL] [Abstract][Full Text] [Related]
35. Alternative splicing of U2AF1 reveals a shared repression mechanism for duplicated exons.
Kralovicova J; Vorechovsky I
Nucleic Acids Res; 2017 Jan; 45(1):417-434. PubMed ID: 27566151
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.
Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS
Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861
[TBL] [Abstract][Full Text] [Related]
37. [Clinical Characteristics and Prognosis of U2AF1 Mutation in Patients with Acute Myeloid Leukemia].
Zhao TY; Guan LX; Zheng WS; Wang ML; Cheng LC; Hu YL; Xu YY; Gu ZY; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):7-11. PubMed ID: 32027245
[TBL] [Abstract][Full Text] [Related]
38. Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence.
Miller CA; Walker JR; Jensen TL; Hooper WF; Fulton RS; Painter JS; Sekeres MA; Ley TJ; Spencer DH; Goll JB; Walter MJ
J Mol Diagn; 2022 Mar; 24(3):219-223. PubMed ID: 35041928
[TBL] [Abstract][Full Text] [Related]
39. Impact of U2AF1 mutations on circular RNA expression in myelodysplastic neoplasms.
Wedge E; Ahmadov U; Hansen TB; Gao Z; Tulstrup M; Côme C; Nonavinkere Srivatsan S; Ahmed T; Jespersen JS; Schlotmann BC; Schöllkopf C; Raaschou-Jensen K; Ødum N; Kjems J; Bak RO; Walter MJ; Grønbæk K; Kristensen LS
Leukemia; 2023 May; 37(5):1113-1125. PubMed ID: 36922625
[TBL] [Abstract][Full Text] [Related]
40. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG
Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
